Man Group
LRMR icon

Man Group’s Larimar Therapeutics LRMR Stock Holding History

Man Group’s Portfolio LRMR Stock Details LRMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$345K Buy
+113,049
New +$449K ﹤0.01% 2142
2026
Q1 		– Sell
-39,225
Closed -$149K – 2495
2025
Q4 		$149K Buy
+39,225
New +$153K ﹤0.01% 2161
2023
Q1 		– Sell
-22,956
Closed -$120K – 1892
2022
Q4 		$94.8K Buy
+22,956
New +$78.4K ﹤0.01% 1913
2018
Q2 		– Sell
-11,411
Closed -$1.02M – 2178
2018
Q1 		$1.02M Buy
+11,411
New +$967K ﹤0.01% 1517

Other funds holding LRMR

Deerfield Management
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DCM
Defilade Capital Management Emeryville, California $747M AUM
Driehaus Capital Management
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RTW Investments
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return

Man Group's LRMR Position: Q2 2026 in Review

Man Group opened a new position in Larimar Therapeutics (LRMR) in Q2 2026: 113,049 shares worth $345K. The stake represents ﹤0.01% of the portfolio and ranks #2142 among its holdings. This is a return to the name: Man Group previously reported a position in LRMR as recently as Q4 2025.

Man Group first reported a position in LRMR in Q1 2018 and has held it in 4 quarters since. The position peaked at $1.02M in Q1 2018. 163 funds tracked by Wall St. Rank hold LRMR as of Q2 2026.

  • Man Group held 113,049 shares of Larimar Therapeutics worth $345K as of Q2 2026.
  • Larimar Therapeutics was a new Man Group position in Q2 2026.
  • Larimar Therapeutics made up ﹤0.01% of Man Group's portfolio in Q2 2026, its #2142 holding.
  • Man Group first reported a position in Larimar Therapeutics in Q1 2018 and has held it in 4 quarters since.
  • Man Group's Larimar Therapeutics position peaked at $1.02M in Q1 2018.
  • 163 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q2 2026.

Based on Man Group's 13F filing for Q2 2026, filed 14 Aug 2026.